@article{TAU1112,
author = {Amy M Pick and Zara Risoldi Cochrane},
title = {Identification of biomarkers in pazopanib treated patients with renal cell carcinoma},
journal = {Translational Andrology and Urology},
volume = {2},
number = {2},
year = {2012},
keywords = {},
abstract = {Targeted therapy has become the mainstay in the treatment of renal cell carcinoma (RCC). That being said, it is difficult to predict which patients will respond to targeted therapy. A recent article published in The Lancet Oncology attempts to identify biomarkers in patients receiving pazopanib that may be helpful in the clinical management of renal cell carcinoma.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/1112}
}